tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR
Advertisement

Paradigm Biopharmaceuticals (PAR) Revenue

Compare
32 Followers

Paradigm Biopharmaceuticals Revenue

Paradigm Biopharmaceuticals had a revenue of 35.42K in the quarter ending Jun 30, 2025, with 112.10%. This bring the company's revenue in the last twelve months to 52.12K, Increased -36.82%. In the fiscal year ending Dec 31, 2025, Paradigm Biopharmaceuticals had annual revenue of 52.12K with -20.79% growth.
Revenue (ttm)
52.12K
Revenue Growth
-20.79%
P/S Ratio
2883.85
Revenue/Employee
Employees
Market Cap
$150.31M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
52.12K-13.68K+79.21%
Dec 31, 2024
65.80K19.04K+140.72%
Dec 31, 2023
46.76K-32.46K+59.02%
Dec 31, 2022
79.22K58.67K+385.54%
Dec 31, 2021
20.55K-2,055,000.00%
Dec 31, 2020
-2.98M
Dec 31, 2019
2.98M301.50K+111.24%
Dec 31, 2018
2.68M859.20K+147.12%
Dec 31, 2017
1.82M532.71K+141.28%
Dec 31, 2016
1.29M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis